Search
LAVA Therapeutics NV
LVTXAdd to Watchlist
1.740USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
45.77MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Fri, Nov 21
Updated: Fri, Nov 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Shay Capital LLC
9.69%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi SA
7.30%
Merck & Co Inc
4.37%
Other
63.27%
Shareholders
Shareholders
Proportion
Shay Capital LLC
9.69%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi SA
7.30%
Merck & Co Inc
4.37%
Other
63.27%
Shareholder Types
Shareholders
Proportion
Corporation
3.86%
Individual Investor
0.86%
Other
95.28%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
49
7.26M
27.59%
-4.78M
2025Q3
45
7.48M
28.43%
-4.70M
2025Q2
48
18.32M
69.64%
-2.74M
2025Q1
59
22.25M
84.60%
-1.27M
2024Q4
61
18.80M
71.50%
-11.80K
2024Q3
56
15.93M
60.60%
-3.34M
2024Q2
58
16.07M
61.13%
-4.19M
2024Q1
58
16.06M
61.10%
-4.38M
2023Q4
51
18.10M
68.85%
+283.15K
2023Q3
52
18.00M
68.48%
-418.56K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Shay Capital LLC
--
0%
-2.55M
-100.00%
Redmile Group, LLC
--
0%
-2.07M
-100.00%
BML Capital Management LLC
--
0%
-1.97M
-100.00%
Cooperatieve Gilde Healthcare IV UA
--
0%
-4.41M
-100.00%
Hurly (Stephen A.)
--
0%
-5.00K
-100.00%
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AltShares Event-Driven ETF
0%
AltShares Event-Driven ETF
Proportion0%